PHOTO ESSAY: Coal miners with black lung fight Trump administration rollback of safety protections

In Oak Hill, West Virginia, respiratory therapist Lisa Emery is deeply concerned about the rising number of coal miners suffering from black lung disease, particularly those in their 30s and 40s. As she cares for these miners, she sees firsthand the impact of their deteriorating health on their families and the community. This issue highlights the ongoing struggles faced by workers in the coal industry and raises questions about government support and health policies. The plight of these miners is a stark reminder of the sacrifices made by the working class and the urgent need for better healthcare solutions.

Eli Lilly's CEO, David Ricks, recently discussed a new agreement with the Trump administration aimed at reducing the prices of their weight loss drug, Zepbound. This deal is significant as it reflects a growing trend towards making essential medications more affordable for consumers, potentially improving access to treatment for many individuals struggling with weight management.

SNAP recipients are facing a dire situation as delays in November payments leave many without food. A judge has intervened, ordering the Trump administration to ensure that benefits are distributed by Friday. This delay is critical because it affects the most vulnerable populations who rely on these benefits for their daily sustenance, highlighting the urgent need for timely assistance.

A federal judge in Rhode Island has mandated that the Trump administration must deliver full SNAP benefits to states by Friday. This decision is significant as it ensures that states receive the necessary funds to support low-income families who rely on these benefits for food security, especially during challenging economic times.

A federal judge in Rhode Island has ordered the Trump administration to ensure full funding for SNAP benefits in November, a crucial decision for many families relying on this support. This ruling highlights the ongoing legal battles over social welfare programs and their funding, emphasizing the importance of food assistance during challenging times.

The Trump administration is on the verge of finalizing a deal with two major drug companies to significantly lower the prices of weight-loss medications. This agreement could bring the cost of the lowest doses of Zepbound and Wegovy down to as low as $149 a month, making these treatments more accessible to those struggling with weight management. This is important as it could lead to improved health outcomes for many individuals who need these medications but have been deterred by high costs.